| Not Yet Recruiting | JY016 Injection in Patients With Advanced Solid Tumors Expressing EGFR Solid Cancers | Phase 1 / Phase 2 | 2026-04-30 |
| Not Yet Recruiting | A Phase Ia Single Ascending-Dose Study of Subcutaneous EB070 Injection in Healthy Volunteers Health Adult Subjects | Phase 1 | 2026-03-01 |
| Not Yet Recruiting | A Phase I Clinical Trial of JH013 Injection Healthy Subjects (HS) | Phase 1 | 2024-10-31 |
| Recruiting | Nimotuzumab Combined With Paclitaxel for Recurrent Metastatic Gastric or Esophagogastric Junction Adenocarcino Gastric or Esophagogastric Junction Adenocarcinoma | Phase 3 | 2024-08-01 |
| Not Yet Recruiting | A Study of Nimotuzumab Plus Concurrent Chemoradiotherapy Sequential Maintenance Treatment for Cervical Carcino Cervical Cancer | Phase 3 | 2024-04-01 |
| Not Yet Recruiting | Nimotuzumab Combined With Trifluridine/Tipiracil in the Treatment of Refractory Metastatic Colorectal Cancer Refractory Metastatic Colorectal Cancer | Phase 3 | 2024-04-01 |
| Unknown | Safety and Preliminary Clinical Activity of Itolizumab in ARDS Acute Respiratory Distress Syndrome | Phase 1 | 2023-12-31 |
| Unknown | Safety and Preliminary Clinical Activity of Itolizumab in Dermatomyositis Dermatomyositis, Adult Type | Phase 1 | 2023-12-30 |
| Unknown | Safety and Clinical Activity of Itolizumab in aGVHD Acute Graft Versus Host Disease | Phase 1 | 2023-05-19 |
| Completed | A Real-world Study of the Efficacy and Safety of Nimotuzumab in Combination With Chemoradiotherapy for LASCCHN Locally Advanced Head and Neck Squamous Cell Carcinoma | — | 2021-10-08 |
| Active Not Recruiting | A Trial of Nimotuzumab and Pinkiller Efficacy and Pain in Advanced Head and Neck Squamous Cell Carcinoma Head and Neck Cancer | Phase 4 | 2021-05-15 |
| Unknown | Nimotuzumab in Combined With Chemoradiotherapy to Treat the Newly Diagnosed Diffuse Intrinsic Pontine Glioma i Diffuse Intrinsic Pontine Glioma | Phase 3 | 2021-04-03 |
| Completed | Nimotuzumab in Combined With Chemotherapy for Treatment of IVB Stage,Rrecurrent or Persistent Cervical Carcino Cervical Squamous Cell Carcinoma, Persistent | Phase 3 | 2017-07-06 |
| Unknown | Nimotuzumab in Combined With Paclitaxel and Cisplatin for Treatment of Metastatic Esophageal Squamous Cell Car Esophageal Squamous Cell Carcinomas | Phase 3 | 2015-11-01 |
| Unknown | Phase IV Clinical Trial of Nimotuzumab in the Treatment of Nasopharyngeal Carcinoma Nasopharyngeal Carcinoma | Phase 4 | 2015-08-01 |
| Completed | A Study of Nimotuzumab Combinated With Gemcitabine in K-RAS Wild-type Locally Advanced and Metastatic Pancreat Pancreatic Cancer | Phase 3 | 2015-04-01 |
| Terminated | Tolerability, Safety and Pharmacokinetic Study of Humanized Anti-CD6 Monoclonal Antibody Injection in Chinese Psoriasis | Phase 1 | 2014-10-01 |
| Unknown | Study of Nimotuzumab in Combination With Neoadjuvant Chemotherapy for Cervical Cancer Cervical Cancer | Phase 2 | 2013-01-01 |
| Unknown | Pharmacokinetics Study of Nimotuzumab in Patients With Solid Tumors Solid Tumors | Phase 1 | 2012-11-01 |
| Unknown | Nimotuzumab in Combination With Radiochemotherapy for Patients With Stage IIIA/IIIB Non-small Cell Lung Cancer Non-small Cell Lung Cancer | N/A | 2011-03-01 |
| Unknown | Nimotuzumab in Combination With Chemoradiation for Local Advanced Esophageal Squamous Cell Carcinoma Squamous Cell Carcinoma | Phase 2 | 2010-09-01 |
| Completed | Nimotuzumab Plus Radiotherapy With Concomitant and Adjuvant Temozolomide for Cerebral Glioblastoma Glioblastoma | Phase 2 | 2010-08-18 |
| Unknown | Nimotuzumab in Combination With Chemoradiation for Nasopharyngeal Cancer Nasopharyngeal Cancer | Phase 3 | 2009-10-01 |
| Withdrawn | Nimotuzumab in Combination With Cisplatin and Docetaxel for Patients With Advanced Non-small Cell Lung Cancer Non-small Cell Lung Cancer | Phase 1 | 2009-09-01 |
| Terminated | Nimotuzumab Plus Docetaxel in Chemotherapy-Refractory/Resistant Patients With Advanced Non-Small-Cell Lung Can Advanced Non-Small Cell Lung Cancer | Phase 2 | 2009-08-01 |
| Completed | Nimotuzumab in Combination With Chemoradiation for Esophageal Cancer Advanced Esophageal | Phase 1 | 2009-07-01 |
| Completed | Phase IIa Study of Nimotuzumab to Treat Colorectal Cancer Colorectal Cancer | Phase 1 / Phase 2 | 2009-07-01 |
| Completed | Nimotuzumab in Combination With Radiotherapy for Esophageal Cancer Esophageal | Phase 2 | 2008-11-01 |